| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.04 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.063 | 0.05 |